Point72 Asset Management »

Tscan Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $15k 15k 1.00

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Group
BlackRock
Standard Life Aberdeen
Deer Management
Renaissance Technologies
DC Funds
Geode Capital Management
Millennium Management
Two Sigma Investments
Citadel Advisors
Jane Street
Marshall Wace

View all funds holding Tscan Therapeutics